Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis.
- J. Klečka, L. Holubec, +8 authors J. Stolz
- Medicine
- Anticancer research
- 1 February 2010
BACKGROUND
Early diagnosis of prostate cancer (PCa) in an organ-confined stage following radical treatment is the only potential curative approach in PCa. Prostatic-specific antigen (PSA) is very… Expand
Oral vinorelbine in metastatic breast cancer: a review of current clinical trial results.
BACKGROUND
Oral chemotherapy is one of the options for the treatment of endocrine non-responsive metastatic breast cancer.
PATIENTS AND METHODS
A search of the online PubMed database was undertaken… Expand
Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study.
- P. Pazdiora, S. Svobodová, +12 authors O. Topolčan
- Medicine
- Anticancer research
- 1 October 2011
BACKGROUND
Many studies have demonstrated the relationship between vitamin D and cancer of many different sites, including of the breast, colorectum, prostate and lung. Most epidemiological studies… Expand
Cancer incidence and mortality in the Czech Republic.
- L. Dušek, J. Mužík, E. Gelnarová, J. Finek, R. Vyzula, J. Abrahámová
- Medicine
- Klinicka onkologie : casopis Ceske a Slovenske…
- 15 December 2014
BACKGROUNDS
The Czech Republic is ranked among those countries with the highest cancer burden in Europe and worldwide. The purpose of this study is to summarize long-term trends in the cancer burden… Expand
18F-FDG-PET/CT in potentially advanced renal cell carcinoma: a role in treatment decisions and prognosis estimation.
- J. Ferda, E. Ferdová, +4 authors B. Kreuzberg
- Medicine
- Anticancer research
- 1 June 2013
AIM
to assess the influence of positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose ((18)F-FDG-PET/CT) on the treatment decision in renal cell carcinoma and to assess the… Expand
Uroweb, webový portál pro analýzu a vizualizaci epidemiologie,diagnostiky a léčby urologických malignit
- J. Mužík, L. Dušek, M. Babjuk, M. Kubásek, J. Finek, L. Petruželka
- Medicine
- 2009
Projekt Uroweb.cz je webový portal urcený vsem, kteři se
zabývaji nebo zajimaji o urologicke malignity. Jeho cilem je
prezentace strategických dat a významu ceske urologie v lecbě
urologických… Expand
- 4
- 2
Cancer epidemiology in Central and South Eastern European countries
- E. Vrdoljak, M. Wojtukiewicz, +6 authors A. Croitoru
- Medicine, Geography
- Croatian medical journal
- 1 August 2011
Aim To collect cancer epidemiology data in South Eastern European countries as a basis for potential comparison of their performance in cancer care. Methods The South Eastern European Research… Expand
Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
- M. Pešta, L. Holubec, +8 authors R. Cerný
- Biology, Medicine
- Anticancer research
- 1 September 2005
BACKGROUND
An essential step in the process of tumor invasion and metastasis involves the degradation of tissue barriers in the extracellular matrix (ECM), particularly in the basal membrane (BM).… Expand
The dominant role of G12C over other KRAS mutation types in the negative prediction of efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
- O. Fiala, M. Pešek, J. Finek, L. Benesova, B. Belšánová, Marek Minarik
- Biology, Medicine
- Cancer genetics
- 2013
The role of KRAS mutations in molecular targeted therapy by epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC) has not been fully… Expand